Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

Pharma — Maj 2022

4 Indlæg 1 Posters 0 Visninger

P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#1

Teva nedjusterer salgsforventningerne https://proinvestor.com/investornyt/817685/teva-nedjusterer-salgsforventningerne
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#2

Lundbeck Q1: Nøgleprodukter overrasker positivt https://proinvestor.com/investornyt/822611/lundbeck-q1-nogleprodukter-overrasker-positivt
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#3

Lundbeck/Sydbank: Stærkt regnskab bør give positiv aktiereaktion - NY https://proinvestor.com/investornyt/822639/lundbeck-sydbank-staerkt-regnskab-bor-give-positiv-aktiereaktion-ny
1 Reply Last reply

0
H Offline
H Offline
Helge_LarsenPI-redaktør

wrote on sidst redigeret af

#4

Q&A med CEO Adam Steensberg fra Zealand Pharma starter kl. 15.
1 Reply Last reply

0
P Offline
P Offline
ProinvestorNEWS

wrote on sidst redigeret af

#5

Test
1 Reply Last reply

0

Hello! It looks like you're interested in this conversation, but you don't have an account yet.

Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

With your input, this post could be even better 💗

Tilmeld Log ind